Beta Blockers
Mostrando 1-12 de 180 artigos, teses e dissertações.
-
1. Pode-se usar betabloqueador em paciente com asma?
Em geral, não se recomenda o uso de betabloqueadores em doenças que cursam com broncoespasmo, como asma ou doença pulmonar obstrutiva crônica (DPOC). História de broncoespasmo relacionado ao betabloqueador é contraindicação absoluta ao uso.
Os possíveis efeitos prejudiciais dos betabloqueadores são o aumento da obstrução brônquica e da
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Heart rate turbulence assessed through ergometry after myocardial infarction: a feasibility study
ABSTRACT BACKGROUND: Coronary artery disease is an important cause of morbidity and mortality. The impact of ventricular arrhythmias with impaired cardiac vagal activity is one of the most recently studied prognostic factors. However, there are no studies evaluating the phenomenon of heart rate turbulence (HRT) during physical exertion. OBJECTIVE: To stu
Sao Paulo Medical Journal. Publicado em: 2022
-
3. Treatment of Hepatitis C with Direct-Acting Antivirals does not Induce Significant Arrhythmias
Abstract Background Chronic Hepatitis C (CHC) therapy with direct-acting antivirals (DAAs) has high efficacy and safety, but some cases of bradyarrhythmias have been described. Objective To evaluate heart rhythm disorders during DAA treatments. Methods Forty-eight patients with CHC (mean 61 years of age; 56% males; 73% HCV genotype 1) were evaluated be
International Journal of Cardiovascular Sciences. Publicado em: 2022
-
4. Drug Profile and Therapeutic Adherence of African-Brazilians with Apparent Resistant Hypertension
Abstract Background Resistant hypertension (RH) is manifested by the presence of blood pressure values resistant to antihypertensive therapy. RH is highly prevalent among black individuals, increasing cardiovascular risk in this population and requiring effective control of this comorbidity. Objectives To investigate the medication profile and therapeutic
Int. J. Cardiovasc. Sci.. Publicado em: 2021-06
-
5. Internal Validation of a Risk Score for Prediction of Postoperative Atrial Fibrillation after Cardiac Surgery
Abstract Background: Postoperative atrial fibrillation (POAF) after cardiac surgery has great clinical and economic implications. Many attempts have been made to identify risk factors aiming at a better evaluation of prophylactic treatment strategies. Objective: To perform an internal validation of a risk score for POAF. Methods: A prospective cohort of 1
Int. J. Cardiovasc. Sci.. Publicado em: 2020-04
-
6. Success in the use of oral propranolol in the treatment of infantile hemangioma in nasal tip - Report of two cases,
Abstract Infantile hemangioma is the most common pediatric vascular tumor, with the following risk factors: low birth weight, prematurity, white skin, female gender, multiparity and advanced maternal age. The use of oral and topical beta-blockers, although recent, has emerged as the first line of treatment, with superior safety and efficacy to previously use
An. Bras. Dermatol.. Publicado em: 2020-03
-
7. Internal Validation of a Risk Score for Prediction of Postoperative Atrial Fibrillation after Cardiac Surgery
Abstract Background: Postoperative atrial fibrillation (POAF) after cardiac surgery has great clinical and economic implications. Many attempts have been made to identify risk factors aiming at a better evaluation of prophylactic treatment strategies. Objective: To perform an internal validation of a risk score for POAF. Methods: A prospective cohort of 1
Int. J. Cardiovasc. Sci.. Publicado em: 24/10/2019
-
8. New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality
Resumo Fundamento: A fibrilação auricular de novo no contexto de infarto agudo do miocárdio representa um importante desafio com potencial impacto prognóstico. Objetivo: Determinar a incidência, impacto na terapêutica e mortalidade, e identificar possíveis preditores do aparecimento de fibrilação auricular de novo durante o internamento por infart
Arq. Bras. Cardiol.. Publicado em: 23/09/2019
-
9. Radiofrequency catheter ablation increases mean platelet volume
RESUMO OBJETIVOS A ablação por radiofrequência (ARF) pode aumentar o risco de eventos tromboembólicos. O objetivo foi avaliar o efeito da ARF no volume plaquetário médio (VPM), um indicador de atividade plaquetária. MÉTODO No total de 95 pacientes submetidos à ARF, o VPM foi medido antes e um mês após o procedimento. Oitenta e três pessoas do
Rev. Assoc. Med. Bras.. Publicado em: 12/09/2019
-
10. Secondary prevention of coronary heart disease: a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
ABSTRACT BACKGROUND: Coronary heart disease (CHD) remains a major cause of mortality worldwide and in Brazil. Use of standard medications after CHD has been proven to avoid new events and reduce early mortality. OBJECTIVES: This study aimed to analyze secondary prevention of CHD and its association with the baseline characteristics of the Brazilian Longi
Sao Paulo Med. J.. Publicado em: 29/08/2019
-
11. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves’ disease
RESUMO INTRODUÇÃO: A doença de Graves (DG) é uma doença autoimune caracterizada por hipertireoidismo. As drogas antitireoidianas (DAT) são opções terapêuticas disponíveis. A agranulocitose é uma complicação rara, potencialmente fatal desta terapia. Neste estudo, relatamos um caso de agranulocitose induzida por propiltiouracil (PTU) em paciente
Rev. Assoc. Med. Bras.. Publicado em: 22/07/2019
-
12. Beta-Blocker Type Effect on Substrate Oxidation during HIIE in Heart Failure Patients: Pilot Data
Resumo Os dados sobre efeito do tipo de betabloqueador de terceira e segunda geração na oxidação do substrato, especialmente durante exercícios de alta intensidade, são escassos. O objetivo do estudo é explorar as diferenças de tratamentos com betabloqueadores (betabloqueadores vasodilatadores vs. não-vasodilatadores) na oxidação de substratos dur
Arq. Bras. Cardiol.. Publicado em: 2019-03